Skip to main content
An official website of the United States government

anti-VEGF anticalin PRS-050-PEG40

A pegylated, proprietary lipocalin that targets human vascular endothelial growth factor (VEGF), with potential antineoplastic activity. Pegylated anti-VEGF anticalin PRS-050 specifically targets and binds to VEGF receptor 2 (VEGFR2 or KDR), thereby preventing its activity. This may inhibit angiogenesis and eventually reduce tumor cell growth.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Code name:PRS-050-PEG40
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search